BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32239432)

  • 21. Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
    King AA; Debaun MR; Riccardi VM; Gutmann DH
    Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis: Impact of Family History.
    Malbari F; Spira M; B Knight P; Zhu C; Roth M; Gill J; Abbott R; Levy AS
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e359-e363. PubMed ID: 29683959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study.
    Yan P; Huang R; Hu P; Liu F; Zhu X; Hu P; Yin H; Zhang J; Meng T; Huang Z
    J Neurooncol; 2019 Jul; 143(3):495-503. PubMed ID: 31089923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
    Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
    Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
    Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Analysis of Head and Neck and Non-Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Patel TD; Shaigany K; Fang CH; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):113-20. PubMed ID: 26408559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Nguyen R; Jett K; Harris GJ; Cai W; Friedman JM; Mautner VF
    J Neurooncol; 2014 Jan; 116(2):307-13. PubMed ID: 24166582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second malignancies after autologous hematopoietic cell transplantation in children.
    Danner-Koptik KE; Majhail NS; Brazauskas R; Wang Z; Buchbinder D; Cahn JY; Dilley KJ; Frangoul HA; Gross TG; Hale GA; Hayashi RJ; Hijiya N; Kamble RT; Lazarus HM; Marks DI; Reddy V; Savani BN; Warwick AB; Wingard JR; Wood WA; Sorror ML; Jacobsohn DA
    Bone Marrow Transplant; 2013 Mar; 48(3):363-8. PubMed ID: 22964594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
    Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
    JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
    Miao R; Wang H; Jacobson A; Lietz AP; Choy E; Raskin KA; Schwab JH; Deshpande V; Nielsen GP; DeLaney TF; Cote GM; Hornicek FJ; Chen YE
    Radiother Oncol; 2019 Aug; 137():61-70. PubMed ID: 31078939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
    Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.
    Federico SM; Allewelt HB; Spunt SL; Hudson MM; Wu J; Billups CA; Jenkins J; Santana VM; Furman WL; McGregor LM
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e6-e12. PubMed ID: 24633303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.